The Prototype: Study Suggests AI Tools Decrease Critical Thinking Skills
Plus: A startup bioengineering off-the-shelf arteries, how viruses may cause Alzheimer’s, water-powered satellites and more.
The Misconceptions About Anavex Life Sciences' Blarcamesine Phase 2b/3 Trial In Alzheimer's Disease
Anavex Life Sciences' Blarcamesine trial raises concerns over approval. Learn why AVXL stock is undervalued, reflecting the ...
Verywell Health on MSN10h
What Happens to Your Brain When You Take These 16 Supplements?
While many people take supplements for brain health, the research supporting supplemental nutrients' effects on brain health ...
Alzheimer’s drugs eyed as next big obesity-like opportunity
Investors seeking the next obesity-like market opportunity will be closely watching developments related to treatments for ...
Alzheimer’s Drugs Eyed by Investors Seeking Obesity-Like Gains
Investors seeking the next obesity-like market opportunity will be closely watching developments related to treatments for ...
Could Alzheimer’s treatment drugs be the next big investor opportunity after obesity pills?
Alzheimer’s drugs could unlock a $13 billion market by 2030, with Biogen, Eli Lilly, Novo Nordisk, Roche, and UCB leading the ...
Could This Be the Cure? Targeting Protein Imbalances To Stop Alzheimer’s
Researchers have discovered that suppressing a nucleolar complex can reduce Alzheimer’s-related protein toxicity. Scientists ...
News Medical on MSN21h
Could autophagy enhancement slow aging and combat Alzheimer's?
Aging involves gradual functional decline across various biological systems, including impaired cellular mechanisms such as ...